Mangold L - Search Results

1

Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer.

Guest C, Harris R, Sfanos KS, Shrestha E, Partin AW, Trock B, Mangold L, Bader R, Kozak A, Mclean S, Simons J, Soule H, Johnson T, Lee WY, Gao Q, Aziz S, Stathatou PM, Thaler S, Foster S, Mershin A. Guest C, et al. Among authors: mangold l. PLoS One. 2021 Feb 17;16(2):e0245530. doi: 10.1371/journal.pone.0245530. eCollection 2021. PLoS One. 2021. PMID: 33596212 Free PMC article.

2

Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy.

Potter SR, Miller MC, Mangold LA, Jones KA, Epstein JI, Veltri RW, Partin AW. Potter SR, et al. Among authors: mangold la. Urology. 1999 Nov;54(5):791-5. doi: 10.1016/s0090-4295(99)00328-3. Urology. 1999. PMID: 10565735 Free article.

3

Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy.

Potter SR, Mangold LA, Shue MJ, Taylor DC, Lecksell KL, Epstein JI, Walsh PC, Partin AW. Potter SR, et al. Among authors: mangold la. Cancer. 2000 Dec 15;89(12):2577-86. Cancer. 2000. PMID: 11135219

4

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.

Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Partin AW, et al. Among authors: mangold la. Urology. 2001 Dec;58(6):843-8. doi: 10.1016/s0090-4295(01)01441-8. Urology. 2001. PMID: 11744442

5

Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.

Veltri RW, Miller MC, Mangold LA, O'Dowd GJ, Epstein JI, Partin AW. Veltri RW, et al. J Urol. 2002 Jul;168(1):100-4. J Urol. 2002. PMID: 12050500

6

Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men.

Sokoll LJ, Mangold LA, Partin AW, Epstein JI, Bruzek DJ, Dunn W, Mohr P, Wallerson G, Chan DW. Sokoll LJ, et al. Urology. 2002 Oct;60(4 Suppl 1):18-23. doi: 10.1016/s0090-4295(02)01692-8. Urology. 2002. PMID: 12384158

7

Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis.

Sokoll LJ, Chan DW, Mikolajczyk SD, Rittenhouse HG, Evans CL, Linton HJ, Mangold LA, Mohr P, Bartsch G, Klocker H, Horninger W, Partin AW. Sokoll LJ, et al. Among authors: mangold la. Urology. 2003 Feb;61(2):274-6. doi: 10.1016/s0090-4295(02)02398-1. Urology. 2003. PMID: 12597929

8

Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer.

Hlavaty JJ, Partin AW, Shue MJ, Mangold LA, Derby J, Javier T, Kelley S, Stieg A, Briggman JV, Hass GM, Wu YJ. Hlavaty JJ, et al. Urology. 2003 Jun;61(6):1261-5. doi: 10.1016/s0090-4295(03)00036-0. Urology. 2003. PMID: 12809926

9

Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer.

Khan MA, Partin AW, Mangold LA, Epstein JI, Walsh PC. Khan MA, et al. Urology. 2003 Nov;62(5):866-71. doi: 10.1016/s0090-4295(03)00674-5. Urology. 2003. PMID: 14624910

10

Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.

Khan MA, Walsh PC, Miller MC, Bales WD, Epstein JI, Mangold LA, Partin AW, Veltri RW. Khan MA, et al. Cancer. 2003 Dec 15;98(12):2583-91. doi: 10.1002/cncr.11852. Cancer. 2003. PMID: 14669277 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters